Palavra-chave: 6-NITRODOPAMINE

TAMSULOSIN DOXAZOSIN SILODOSIN EPIDIDYMAL VAS DEFERENS ALFUZOSIN ADRENOCEPTORS CATECHOLAMINES DOPAMINE RECEPTORS AORTA CHELONOIDIS CARBONARIA L-761,626 L-NAME ATRIA DOPAMINE HALOPERIDOL L-741,626 PULMONARY ARTERY ENDOTHELIUM ODQ VAS DEFERENS IDAZOXAN PRE-SYNAPTIC ADRENOCEPTORS TETRODOTOXIN CHRONOTROPISM ENDOTHELIAL NITRIC OXIDE SYNTHASE VENTRICLE PROTEIN KINASE A PHOSPHODIESTERASE HUMAN VAS DEFERENS NITRIC OXIDE EJACULATION INOTROPISM LANGENDORFF'S PREPARATION ATENOLOL LEFT VENTRICULAR DEVELOPED PRESSURE ELECTRICAL-FIELD STIMULATION EPITHELIUM FLUORESCENCE IN-SITU HYBRIDIZATION ASSAYS SEMINAL VESICLES CORPUS CAVERNOSUM NEURONAL NITRIC OXIDE SYNTHASE TYROSINE HYDROXYLASE 6-CYANODOPAMINE DOPAMINERGIC D2-LIKE RECEPTOR RESISTANCE VESSELS RAT ISOLATED RIGHT ATRIUM ( ±)-4-NO2-PROPRANOLOL, ADRENOCEPTOR ANTAGONISTS INDUCIBLE NITRIC OXIDE SYNTHASE ISOLATED URINARY BLADDER CATECHOLAMINE TANDEM MASS SPECTROMETRY SOLUBLE GUANYLATE CYCLASE RAT ISOLATED SEMINAL VESICLES FLUORESCENCE IN SITU HYBRIDIZATION GKT137831 LC-MS/MS HUMAN ISOLATED VAS DEFERENS FLUORESCENCE IN-SITU HYBRIDIZATION